Skye Bioscience, Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

MLA

“Skye Bioscience, Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).” Pharma Business Week, Nov. 2024, p. 1776. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180751408&authtype=sso&custid=ns315887.

APA

Skye Bioscience, Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024). (2024). Pharma Business Week, 1776.

Chicago

“Skye Bioscience, Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).” 2024. Pharma Business Week, November, 1776. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180751408&authtype=sso&custid=ns315887.